↓ Skip to main content

Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

Overview of attention for article published in BMC Cancer, February 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
17 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival
Published in
BMC Cancer, February 2012
DOI 10.1186/1471-2407-12-73
Pubmed ID
Authors

Ana Slipicevic, Ruth Holm, Elisabeth Emilsen, Anne Katrine Ree Rosnes, Danny R Welch, Gunhild M Mælandsmo, Vivi Ann Flørenes

Abstract

Breast cancer metastasis suppressor 1 (BRMS1) blocks metastasis in melanoma xenografts; however, its usefulness as a biomarker in human melanomas has not been widely studied. The goal was to measure BRMS1 expression in benign nevi, primary and metastatic melanomas and evaluate its impact on disease progression and prognosis.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 6%
Unknown 16 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 29%
Other 2 12%
Professor 2 12%
Student > Ph. D. Student 1 6%
Student > Master 1 6%
Other 3 18%
Unknown 3 18%
Readers by discipline Count As %
Medicine and Dentistry 5 29%
Agricultural and Biological Sciences 3 18%
Biochemistry, Genetics and Molecular Biology 2 12%
Immunology and Microbiology 2 12%
Pharmacology, Toxicology and Pharmaceutical Science 2 12%
Other 0 0%
Unknown 3 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2012.
All research outputs
#9,905,803
of 12,372,945 outputs
Outputs from BMC Cancer
#3,021
of 4,558 outputs
Outputs of similar age
#82,460
of 116,386 outputs
Outputs of similar age from BMC Cancer
#11
of 17 outputs
Altmetric has tracked 12,372,945 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,558 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 116,386 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.